<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cetina-Corona</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lopez-Sanchez</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Salinas-Trujano</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mendez-Tenorio</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Barron</surname>
    <given-names>B. L.</given-names>
   </name>
   <name>
    <surname>Torres-Flores</surname>
    <given-names>J.</given-names>
   </name>
  </person-group> (
  <year>2016</year>). 
  <article-title>Peptides derived from glycoproteins H and B of herpes simplex virus type 1 and herpes simplex virus type 2 are capable of blocking herpetic infection 
   <italic>in vitro</italic>.
  </article-title>
  <source>
   <italic>Intervirology</italic>
  </source>
  <volume>59</volume>
  <fpage>235</fpage>â€“
  <lpage>242</lpage>. 
  <pub-id pub-id-type="doi">10.1159/000464134</pub-id>
  <pub-id pub-id-type="pmid">28329739</pub-id>
 </mixed-citation>
</ref>
